Itai Shigeru
Department of Pharmaceutical Engineering and Drug Delivery Science, School of Pharmaceutical Sciences, University of Shizuoka.
Yakugaku Zasshi. 2019;139(3):419-435. doi: 10.1248/yakushi.18-00183.
After 32 years as a researcher in a pharmaceutical company, the author has served as a professor in the Development of Pharmaceutical Engineering and Drug Delivery Science at University of Shizuoka for the past 11 years. The research I was involved in can be categorized into four main items. First, the crystal transformation of clarithromycin (CAM) was focused on to develop the CAM high-loaded sustained release and gastro-floating formulations. Furthermore, the stabilization mechanism of CAM in the gastro-intestinal tract was clarified to elucidate gel formation under conditions of low pH. Second, the development of novel dosage regimens and optimization of formulation design were carried out using powder technology. In this category, a wax matrix formulation for taste masking, highly drug-loaded fine globular granules using a multi-functional rotor processor, and orally disintegrating tablets treated with microwave or high-pressure carbon dioxide were our targets. The third category was the manufacture of dispersion systems including lipid nanoparticles and cubosomes in order to improve the bioavailability and stability of poorly water-soluble drugs. The fourth category was the development and application of novel physical testing methods including investigation of the internal structure of fine granules using microtomography with synchrotron X-ray radiation, dissolution of spherical granules under non-sink conditions, mathematical models to analyze the dissolution behavior of metastable crystals or amorphous drugs and prediction of the available surface area of tablets during dissolution process.
在一家制药公司担任研究员32年后,作者在静冈大学制药工程与药物递送科学专业担任教授已有11年。我参与的研究可分为四个主要项目。第一,聚焦于克拉霉素(CAM)的晶型转变,以开发高载量克拉霉素缓释和胃漂浮制剂。此外,阐明了克拉霉素在胃肠道中的稳定机制,以阐释低pH条件下的凝胶形成。第二,利用粉末技术开展新型给药方案的开发和制剂设计的优化。在此类别中,用于掩味的蜡质基质制剂、使用多功能转子处理器制备的高载药量细小球形颗粒以及经微波或高压二氧化碳处理的口腔崩解片是我们的目标。第三类是制备包括脂质纳米粒和立方液晶相在内的分散体系,以提高难溶性药物的生物利用度和稳定性。第四类是新型物理检测方法的开发与应用,包括使用同步辐射X射线显微断层成像研究细颗粒的内部结构、非漏槽条件下球形颗粒的溶出、分析亚稳晶体或无定形药物溶出行为的数学模型以及预测片剂溶出过程中的有效表面积。